MMR

Analyst Upgrades: Oracle Corporation, Gilead Sciences, Inc., and salesforce.com, inc.

Analysts upwardly revised their ratings and price targets on Oracle Corporation (ORCL), Gilead Sciences, Inc. (GILD), and salesforce.com, inc. (CRM)

Feb 25, 2016 at 9:29 AM
facebook X logo linkedin


Analysts are weighing in on software producer Oracle Corporation (NYSE:ORCL), biotech stock Gilead Sciences, Inc. (NASDAQ:GILD), and cloud concern salesforce.com, inc. (NYSE:CRM). Here's a quick roundup of today's bullish brokerage notes on ORCL, GILD, and CRM.

  • ORCL is 0.7% higher in electronic trading, after Jyske Bank initiated coverage on the stock with a "buy" rating and $42 price target -- a level the shares haven’t seen since last June. Oracle Corporation fell to a two-year low of $33.13 in late January, but has been on the mend, closing at $36.63 Wednesday. Still, near-term option traders have been exceptionally put-skewed of late -- the stock's Schaeffer's put/call open interest ratio (SOIR) of 1.11 is higher than 90% of readings taken in the past year.
  • Citigroup began coverage on GILD with a "buy" rating, boosting the shares 0.9% ahead of the bell. While Gilead Sciences, Inc., has underperformed the S&P 500 Index (SPX) in recent months, it has maintained favor with analysts and option traders alike. Currently, 12 out of 17 brokerage firms rate the security a "buy" or better, without a "sell" in sight. And at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the equity's 50-day call/put volume ratio of 2.92 is in the 98th percentile of its annual range, hinting at a healthier-than-usual appetite for bullish bets of late.
  • CRM is set to surge 10.4% over its Wednesday close of $62.52, after reporting solid fourth-quarter earnings and upping its full-year sales forecast. Since the report, no fewer than eight brokerage firms have adjusted their price targets on the stock, including Wedbush, which increased its target to $95 from $92 -- well into record-high territory. While analysts were already firmly in salesforce.com, inc.'s corner, with 28 "buy" or better ratings and just three "holds," bearish option traders could be hitting the bricks today. At the ISE, CBOE, and PHLX, CRM has racked up a 10-day put/call volume ratio of 0.81 -- higher than 92% of all readings in the last 12 months.
Sign up now for Schaeffer's Opening View newsletter to get a head start on all the major pre-market news!
 

AI has exploded ever since ChatGPT set the world on fire near the end of 2022.

Numerous companies with connections to artificial intelligence have seen their stocks soar.

That includes Nvidia, the poster boy of AI.

Its stock has skyrocketed 716% since ChatGPT’s debut. But here’s the thing …

While everyone’s still counting their money from this first AI boom … Nvidia and countless others have moved on to the next stage.

That includes Big Tech, which is currently making a series of peculiar investments in a few strange companies. This has nothing to do with tech. At least on the surface …

Yet, these strange investments could be the early ripples of a massive wave …Without them, ChatGPT could stop operating … Amazon, Google, Microsoft and more could see profits drop drastically.

In fact, Elon Musk says these investments are critical when it comes to solving the number one problem facing AI.

Now, Silicon Valley legend Michael Robinson has identified two companies that could play a significant role in the solution.

Their stocks just may be the key to AI 2.0.

Find out more about these two companies today.
 (ad)